Insider trade

CEO sold ~$456K of UNH shares in the open market

Traded Aug 21, 2026 · Filed Aug 25, 2026

UnitedHealthUNH

~$456K
Reported value · 1,169 sh @ $390.00: 15K
Holds after · shares reported: −3.0%
stock since the trade · S&P 500 +1.2%, $390.11 → $378.58 on Oct 5

Why it stands out

The boss of UnitedHealth sold $456K of UnitedHealth shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Aug 21, 2026
Reporting period: Not applicable
Filed with the SEC: Aug 25, 2026

CEO$100K–$500K

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$455,910

Shares × reported transaction price

Timing vs results

36 days after results of Jul 16, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $390.11 on Aug 21, 2026, 51% above its 52-week low and 11% below its high, after an 8% drop over the previous 30 trading days

52-week range $259.02 (Mar 27, 2026) to $436.35 (Jul 21, 2026), 74% of the way up, from 251 adjusted closes. 30 trading days earlier: $424.62 on Jul 10, 2026. Describes the past only, not a forecast

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Securities lawsuit open at the trade date

A securities lawsuit naming the company as a defendant was filed on Mar 20, 2026 in the U.S. District Court, District of Columbia. A filing is an allegation, not a finding.

2 such cases were open. FONDS DES MISSIONS v. UNITEDHEALTH GROUP INCORPORATED, docket 1:26-cv-00970, via CourtListener (court records). Nature of suit 850, company named as first defendant